Home/Filings/4/0001602264-19-000001
4//SEC Filing

Venrock Healthcare Capital Partners II, L.P. 4

Accession 0001602264-19-000001

CIK 0001348911other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 4:08 PM ET

Size

15.7 KB

Accession

0001602264-19-000001

Insider Transaction Report

Form 4
Period: 2019-03-18
Transactions
  • Sale

    Common Stock

    2019-03-18$28.75/sh500,000$14,375,0001,544,112 total(indirect: By Funds)
Transactions
  • Sale

    Common Stock

    2019-03-18$28.75/sh500,000$14,375,0001,544,112 total(indirect: By Funds)
Koh Bong Y
10% Owner
Transactions
  • Sale

    Common Stock

    2019-03-18$28.75/sh500,000$14,375,0001,544,112 total(indirect: By Funds)
Transactions
  • Sale

    Common Stock

    2019-03-18$28.75/sh500,000$14,375,0001,544,112 total(indirect: By Funds)
Transactions
  • Sale

    Common Stock

    2019-03-18$28.75/sh500,000$14,375,0001,544,112 total(indirect: By Funds)
Transactions
  • Sale

    Common Stock

    2019-03-18$28.75/sh500,000$14,375,0001,544,112 total(indirect: By Funds)
Shah Nimish P
10% Owner
Transactions
  • Sale

    Common Stock

    2019-03-18$28.75/sh500,000$14,375,0001,544,112 total(indirect: By Funds)
Transactions
  • Sale

    Common Stock

    2019-03-18$28.75/sh500,000$14,375,0001,544,112 total(indirect: By Funds)
Footnotes (2)
  • [F1]Consists of (i) 408,110 shares held by Venrock Healthcare Capital Partners II, L.P. ("VHCP2"), (ii) 165,372 shares held by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 882,461 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3") and (iv) 88,169 shares held by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3").
  • [F2]VHCP Management II, LLC ("VHCPM2") is the general partner of VHCP2 and the manager of VHCP Co-2 and may be deemed to beneficially own these shares. VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these shares. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3 and may be deemed to beneficially own these shares. Each of VHCPM2, VHCPM3, Bong Koh and Nimish Shah expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein.

Issuer

KalVista Pharmaceuticals, Inc.

CIK 0001348911

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001602264

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:08 PM ET
Size
15.7 KB